加拿大安大略省43年间系统性红斑狼疮患者标准化死亡比的演变
该研究基于多伦多狼疮诊所1971至2013年随访的1732例系统性红斑狼疮(SLE)患者,采用间接标准化法计算全因、病因别和年龄别标准化死亡比(SMR)。全因SMR从1970年代的13.5降至近年2.2,动脉粥样硬化、感染和恶性肿瘤的SMR也呈类似下降趋势;年轻患者(19-39岁)的全因SMR明显高于40岁以上患者。
要点
- SLE患者全因SMR从1970年代13.5降至近年2.2,提示管理进步。
- 19-39岁患者全因SMR为12.4,明显高于40岁以上者的3.1。
- 感染、动脉粥样硬化和活动性狼疮是主要死因,年轻患者感染与恶性肿瘤SMR更高。
核心结论
- SLE患者的全因和病因别SMR随时间显著下降,可能反映SLE及部分合并症管理的进步。
- 年轻患者(<40岁)的全因和病因别SMR尤其高。
研究设计与样本
- 回顾性队列研究,纳入1971至2013年多伦多狼疮诊所随访的1732例SLE患者。
- 死因取自死亡证明、尸检报告、病历或家庭医生记录,分为动脉粥样硬化、感染、恶性肿瘤、活动性狼疮和其他。
- 采用间接标准化法,以加拿大安大略省一般人群数据(Statistics Canada)计算SMR。
主要发现
- 死因构成为感染24.5%、动脉粥样硬化15.7%、活动性狼疮13.3%、恶性肿瘤9.6%。
- 全因SMR从1970年代的13.5(95%CI 8.6至18.5)降至近年2.2(95%CI 1.4至3.1)。
- 动脉粥样硬化、感染和恶性肿瘤的SMR随时间呈类似下降趋势。
- 19-39岁患者全因SMR为12.4(95%CI 9.7至15.1),40岁以上为3.1(95%CI 2.6至3.6);年轻患者感染和恶性肿瘤的病因别SMR也更高。
关键数值与推荐
- 全因SMR:1970年代13.5(95%CI 8.6至18.5),近年2.2(95%CI 1.4至3.1)。
- 年龄别全因SMR:19-39岁12.4(95%CI 9.7至15.1),>40岁3.1(95%CI 2.6至3.6)。
- 死因占比:感染24.5%、动脉粥样硬化15.7%、活动性狼疮13.3%、恶性肿瘤9.6%。
临床怎么用
- 应持续关注SLE患者长期死亡风险,尤其感染、动脉粥样硬化和恶性肿瘤。
- 年轻SLE患者(<40岁)死亡风险相对更高,需加强监测与合并症管理。
局限性
- 单中心诊所队列,死因依赖死亡证明、尸检报告、病历或家庭医生记录。
- SMR以安大略省一般人群为参照,采用间接标准化法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Survival in systemic lupus erythematosus (SLE) has improved substantially in the last 50 years. The aim of the present study was to assess the evolution of the all-cause, cause-specific and age-specific standardised mortality ratios (SMRs) of patients with lupus in Ontario, Canada. PATIENTS AND METHODS: Between 1971 and 2013, 1732 patients were followed in the Toronto Lupus Clinic. Causes of death were retrieved from death certificates, autopsy reports, hospital records or the records of the family physicians. They were categorised as atherosclerotic, infectious, malignancy, active lupus and others. For the calculation of the SMR (indirect standardisation method), data from the general population of Ontario, Canada were used (Statistics Canada). RESULTS: Two hundred and forty-nine patients (205 women) died (infections 24.5%, atherosclerosis 15.7%, active lupus 13.3%, malignancy 9.6%); mean age was 53.2±16.6 years and mean disease duration 15.2±11.7 years. The all-cause SMR was substantially decreased from the 1970s (13.5, 95% CI 8.6 to 18.5) to recent years (2.2, 95% CI 1.4 to 3.1). Similar trends were observed for atherosclerosis, infections and malignancies over time. The all-cause age-specific SMR was particularly high in younger (19-39 years old) patients (SMR=12.4, 95% CI 9.7 to 15.1) as compared with individuals older than 40 years (SMR=3.1, 95% CI 2.6 to 3.6). The cause-specific SMR was also higher in younger patients, particularly for infections and malignancies. CONCLUSIONS: The all-cause and cause-specific SMR significantly decreased over time, likely reflecting the advances in the management of SLE and certain comorbidities. The all-cause and cause-specific SMR was particularly high for younger patients (<40 years old).
引用
- Tselios K, Gladman DD, Sheane BJ, et al. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Ann Rheum Dis. 2019. PMID: 30992296. doi:10.1136/annrheumdis-2018-214802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。